**Author details**

Ana Luisa Pedroso Ayub1 , Debora D'Angelo Papaiz1 , Roseli da Silva Soares1,2 and Miriam Galvonas Jasiulionis1 \*

1 Pharmacology Department, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil

2 Department of Neurology, Universidade de São Paulo, São Paulo, Brazil

\*Address all correspondence to: mjasiulionis@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**131**

*The Function of lncRNAs as Epigenetic Regulators DOI: http://dx.doi.org/10.5772/intechopen.88071*

> plasma of patients with gastric cancer. Anticancer Research. 2013;**33**:3185-3193

[9] Kapranov P, Cheng J, Dike S, Nix DA,

[10] Mattick JS, Amaral PP, Dinger ME, Mercer TR, Mehler MF. RNA regulation of epigenetic processes. BioEssays. 2009;**31**:51-59. DOI: 10.1002/

[11] Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by non-coding RNAs. Cell.

[12] Martianov I, Ramadass A, Serra Barros A, Chow N, Akoulitchev A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature. 2007;**445**:666-670. DOI: 10.1038/

[13] Feng J. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes & Development. 2006;**20**:1470-1484.

[14] Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, Pena R, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes & Development. 2008;**22**:756-

DOI: 10.1101/gad.1416106

769. DOI: 10.1101/gad.455708

[15] Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates

Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;**80**(316):1484-1488. DOI: 10.1126/

science.1138341

bies.080099

2007;**129**:1311-1323

nature05519

[1] Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the *H19* gene may function as an RNA. Molecular and Cellular Biology. 1990;**10**:28-36. Available from: http://www.ncbi.nlm.

[2] Guttman M, Rinn JL. Modular regulatory principles of large noncoding RNAs. Nature. 2012;**482**:339- 346. DOI: 10.1038/nature10887

[3] Villegas V, Zaphiropoulos P. Neighboring gene regulation by antisense long non-coding RNAs. International Journal of Molecular Sciences. 2015;**16**:3251-3266. DOI:

[4] Pereira TC. Introdução ao Universo dos Non-coding RNAs. 1st ed. Ribeirão

Trapnell C, Williams A, Henao-Mejia J, Sun L, et al. Topological organization of multichromosomal regions by the long intergenic noncoding RNA firre. Nature Structural & Molecular Biology. 2014;**21**:198-206. DOI: 10.1038/

[5] Hacisuleyman E, Goff LA,

[6] Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular Cell. 2010;**39**:925-938. DOI: 10.1016/j.

[7] Sun Z, Yang S, Zhou Q, Wang G, Song J, Li Z, et al. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Molecular Cancer. 2018;**17**:82. DOI:

[8] Tomohiro A, Daisuke I, Hirotaka K, Shuhei K, Atsushi S, Katsutoshi S, et al. Circulating long non-coding RNAs in

10.1186/s12943-018-0831-z

10.3390/ijms16023251

Preto: SBG; 2017

nsmb.2764

molcel.2010.08.011

nih.gov/pubmed/1688465

**References**

*The Function of lncRNAs as Epigenetic Regulators DOI: http://dx.doi.org/10.5772/intechopen.88071*

## **References**

*Non-Coding RNAs*

**130**

**Author details**

Ana Luisa Pedroso Ayub1

São Paulo, São Paulo, Brazil

and Miriam Galvonas Jasiulionis1

, Debora D'Angelo Papaiz1

2 Department of Neurology, Universidade de São Paulo, São Paulo, Brazil

1 Pharmacology Department, Escola Paulista de Medicina, Universidade Federal de

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

\*

\*Address all correspondence to: mjasiulionis@gmail.com

provided the original work is properly cited.

, Roseli da Silva Soares1,2

[1] Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the *H19* gene may function as an RNA. Molecular and Cellular Biology. 1990;**10**:28-36. Available from: http://www.ncbi.nlm. nih.gov/pubmed/1688465

[2] Guttman M, Rinn JL. Modular regulatory principles of large noncoding RNAs. Nature. 2012;**482**:339- 346. DOI: 10.1038/nature10887

[3] Villegas V, Zaphiropoulos P. Neighboring gene regulation by antisense long non-coding RNAs. International Journal of Molecular Sciences. 2015;**16**:3251-3266. DOI: 10.3390/ijms16023251

[4] Pereira TC. Introdução ao Universo dos Non-coding RNAs. 1st ed. Ribeirão Preto: SBG; 2017

[5] Hacisuleyman E, Goff LA, Trapnell C, Williams A, Henao-Mejia J, Sun L, et al. Topological organization of multichromosomal regions by the long intergenic noncoding RNA firre. Nature Structural & Molecular Biology. 2014;**21**:198-206. DOI: 10.1038/ nsmb.2764

[6] Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular Cell. 2010;**39**:925-938. DOI: 10.1016/j. molcel.2010.08.011

[7] Sun Z, Yang S, Zhou Q, Wang G, Song J, Li Z, et al. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Molecular Cancer. 2018;**17**:82. DOI: 10.1186/s12943-018-0831-z

[8] Tomohiro A, Daisuke I, Hirotaka K, Shuhei K, Atsushi S, Katsutoshi S, et al. Circulating long non-coding RNAs in

plasma of patients with gastric cancer. Anticancer Research. 2013;**33**:3185-3193

[9] Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;**80**(316):1484-1488. DOI: 10.1126/ science.1138341

[10] Mattick JS, Amaral PP, Dinger ME, Mercer TR, Mehler MF. RNA regulation of epigenetic processes. BioEssays. 2009;**31**:51-59. DOI: 10.1002/ bies.080099

[11] Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by non-coding RNAs. Cell. 2007;**129**:1311-1323

[12] Martianov I, Ramadass A, Serra Barros A, Chow N, Akoulitchev A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature. 2007;**445**:666-670. DOI: 10.1038/ nature05519

[13] Feng J. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes & Development. 2006;**20**:1470-1484. DOI: 10.1101/gad.1416106

[14] Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, Pena R, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes & Development. 2008;**22**:756- 769. DOI: 10.1101/gad.455708

[15] Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates

tumour biology. Nature. 2010;**465**:1033- 1038. DOI: 10.1038/nature09144

[16] Yao H, Duan M, Lin L, Wu C, Fu X, Wang H, et al. TET2 and *MEG3* promoter methylation is associated with acute myeloid leukemia in a Hainan population. Oncotarget. 2017;**8**:18337- 18347. DOI: 10.18632/oncotarget.15440

[17] Deng W, Wang J, Zhang J, Cai J, Bai Z, Zhang Z. TET2 regulates LncRNA-*ANRIL* expression and inhibits the growth of human gastric cancer cells. IUBMB Life. 2016;**68**:355-364. DOI: 10.1002/iub.1490

[18] Monnier P, Martinet C, Pontis J, Stancheva I, Ait-Si-Ali S, Dandolo L. *H19* lncRNA controls gene expression of the imprinted gene network by recruiting MBD1. Proceedings of the National Academy of Sciences. 2013;**110**:20693-20698. DOI: 10.1073/ pnas.1310201110

[19] Zhou J, Yang L, Zhong T, Mueller M, Men Y, Zhang N, et al. *H19* lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nature Communications. 2015;**6**:10221. DOI: 10.1038/ncomms10221

[20] Kanduri C. Long noncoding RNAs: Lessons from genomic imprinting. Biochimica et Biophysica Acta, Gene Regulatory Mechanisms. 2016;**1859**:102-111. DOI: 10.1016/j. bbagrm.2015.05.006

[21] Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: Spatial amplifiers that control nuclear structure and gene expression. Nature Reviews. Molecular Cell Biology. 2016;**17**:756-770. DOI: 10.1038/nrm.2016.126

[22] Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;**472**:120-126. DOI: 10.1038/nature09819

[23] Grote P, Wittler L, Währisch S, Hendrix D, Beisaw A, Macura K, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Developmental Cell. 2014;**24**:206-214. DOI: 10.1016/j.devcel.2012.12.012.The

[24] Xu T, Huang M, Xia R, Liu X, Sun M, Yin L, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. Journal of Hematology & Oncology. 2014;**7**:63. DOI: 10.1186/s13045-014-0063-7

[25] Huang Y, Chang C, Lee S, Jou Y, Shih H-M. *Xist* reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Oncotarget. 2016;**7**:43256-43266. DOI: 10.18632/oncotarget.9673

[26] Dinescu S, Ignat S, Lazar A, Constantin C, Neagu M, Costache M. Epitranscriptomic signatures in lncRNAs and their possible roles in cancer. Genes (Basel). 2019;**10**:52. DOI: 10.3390/genes10010052

[27] Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, et al. MALAT1: A druggable long noncoding RNA for targeted anti-cancer approaches. Journal of Hematology & Oncology. 2018;**11**:63. DOI: 10.1186/ s13045-018-0606-4

[28] Tee AE, Ling D, Nelson C, Atmadibrata B, Dinger ME, Xu N, et al. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget. 2014;**5**:1793-1804. DOI: 10.18632/ oncotarget.1785

[29] Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms

**133**

*The Function of lncRNAs as Epigenetic Regulators DOI: http://dx.doi.org/10.5772/intechopen.88071*

2015;**36**:3611-3619. DOI: 10.1007/

[36] Lv X, Lian G, Wang H, Song E, Yao H, Wang M. Long noncoding RNA *HOTAIR* is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;**8**:1-6. DOI: 10.1371/journal.

[37] Teschendorff AE, Lee S, Jones A, Fiegl H, Kalwa M, Wagner W, et al. *HOTAIR* and its surrogate DNA methylation signature indicate

carboplatin resistance in ovarian cancer. Genome Medicine. 2015;**7**:108. DOI:

[38] Yan Z, He L, Qiu J, Deng W, Lu J, Yuan Z, et al. LncRNA *HOTAIR* participates in the development and progression of adrenocortical carcinoma via regulating cell cycle. European Review for Medical and Pharmacological Sciences. 2018;**22**:6640-6649. DOI: 10.26355/

10.1186/s13073-015-0233-4

eurrev\_201810\_16139

[39] Wang B, Qu X-L, Liu J, Lu J, Zhou Z-Y. *HOTAIR* promotes

Cellular Physiology. 2019;**234**: 6173-6181. DOI: 10.1002/jcp.27394

10.1007/s13277-014-2523-7

journal.pone.0000845

[40] Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F, et al. Long noncoding RNA *HOTAIR* involvement in cancer. Tumor Biology. 2014;**35**:9531-9538. DOI:

[41] Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-Lail R, Hochberg A, et al. The *H19* non-coding RNA is essential for human tumor growth. PLoS One. 2007;**2**:e845. DOI: 10.1371/

[42] Dey BK, Pfeifer K, Dutta A. The *H19* long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle

osteosarcoma development by sponging miR-217 and targeting ZEB1. Journal of

s13277-014-2998-2

pone.0063516

chromatin state to promote cancer metastasis. Nature. 2010;**464**:1071-1076.

[30] Dou J, He X, Wu D, Li M, Wu S, Zhang R, et al. Decreasing lncRNA *HOTAIR* expression inhibits human colorectal cancer stem cells. American Journal of Translational Research.

[31] Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short diseasefree survival in human non-small cell lung cancer. Biochemical and Biophysical Research Communications. 2013;**436**:319-324. DOI: 10.1016/j.

[32] Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, et al. Clinical significance of the expression of long non-coding RNA *HOTAIR* in primary hepatocellular carcinoma. Oncology Reports. 2013;**29**:946-950. DOI: 10.3892/

[33] Sun W, Yang Y, Xu C, Xie Y, Guo J. Roles of long noncoding RNAs in gastric cancer and their clinical applications. Journal of Cancer Research and Clinical Oncology. 2016;**142**:2231-2237. DOI:

10.1007/s00432-016-2183-7

[34] Svoboda M, Slyskova J, Schneiderova M, Makovicky P, Bielik L, Levy M, et al. *HOTAIR* long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis. 2014;**35**:1510-1515.

DOI: 10.1093/carcin/bgu055

Haifeng Q. *HOTAIR* enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer. Tumor Biology.

[35] Jing L, Yuan W, Ruofan D, Jinjin Y,

DOI: 10.1038/nature08975

2016;**8**:98-108

bbrc.2013.05.101

or.2012.2219

*The Function of lncRNAs as Epigenetic Regulators DOI: http://dx.doi.org/10.5772/intechopen.88071*

*Non-Coding RNAs*

tumour biology. Nature. 2010;**465**:1033-

[23] Grote P, Wittler L, Währisch S, Hendrix D, Beisaw A, Macura K, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Developmental Cell. 2014;**24**:206-214. DOI: 10.1016/j.devcel.2012.12.012.The

[24] Xu T, Huang M, Xia R, Liu X, Sun M, Yin L, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. Journal of Hematology & Oncology. 2014;**7**:63. DOI: 10.1186/s13045-014-0063-7

[25] Huang Y, Chang C, Lee S, Jou Y,

phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Oncotarget. 2016;**7**:43256-43266. DOI:

Shih H-M. *Xist* reduction in breast cancer upregulates AKT

10.18632/oncotarget.9673

10.3390/genes10010052

s13045-018-0606-4

oncotarget.1785

[28] Tee AE, Ling D, Nelson C, Atmadibrata B, Dinger ME, Xu N, et al. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget. 2014;**5**:1793-1804. DOI: 10.18632/

[29] Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms

[26] Dinescu S, Ignat S, Lazar A, Constantin C, Neagu M, Costache M. Epitranscriptomic signatures in lncRNAs and their possible roles in cancer. Genes (Basel). 2019;**10**:52. DOI:

[27] Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, et al. MALAT1: A druggable long noncoding RNA for targeted anti-cancer approaches. Journal of Hematology & Oncology. 2018;**11**:63. DOI: 10.1186/

[16] Yao H, Duan M, Lin L, Wu C, Fu X,

promoter methylation is associated with acute myeloid leukemia in a Hainan population. Oncotarget. 2017;**8**:18337- 18347. DOI: 10.18632/oncotarget.15440

[17] Deng W, Wang J, Zhang J, Cai J, Bai Z, Zhang Z. TET2 regulates

[18] Monnier P, Martinet C, Pontis J, Stancheva I, Ait-Si-Ali S, Dandolo L. *H19* lncRNA controls gene expression of the imprinted gene network by recruiting MBD1. Proceedings of the National Academy of Sciences. 2013;**110**:20693-20698. DOI: 10.1073/

[19] Zhou J, Yang L, Zhong T, Mueller M, Men Y, Zhang N, et al. *H19* lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nature Communications. 2015;**6**:10221. DOI: 10.1038/ncomms10221

[20] Kanduri C. Long noncoding RNAs: Lessons from genomic

bbagrm.2015.05.006

DOI: 10.1038/nrm.2016.126

DOI: 10.1038/nature09819

imprinting. Biochimica et Biophysica Acta, Gene Regulatory Mechanisms. 2016;**1859**:102-111. DOI: 10.1016/j.

[21] Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: Spatial amplifiers that control nuclear structure and gene expression. Nature Reviews. Molecular Cell Biology. 2016;**17**:756-770.

[22] Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;**472**:120-126.

DOI: 10.1002/iub.1490

pnas.1310201110

LncRNA-*ANRIL* expression and inhibits the growth of human gastric cancer cells. IUBMB Life. 2016;**68**:355-364.

1038. DOI: 10.1038/nature09144

Wang H, et al. TET2 and *MEG3*

**132**

chromatin state to promote cancer metastasis. Nature. 2010;**464**:1071-1076. DOI: 10.1038/nature08975

[30] Dou J, He X, Wu D, Li M, Wu S, Zhang R, et al. Decreasing lncRNA *HOTAIR* expression inhibits human colorectal cancer stem cells. American Journal of Translational Research. 2016;**8**:98-108

[31] Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short diseasefree survival in human non-small cell lung cancer. Biochemical and Biophysical Research Communications. 2013;**436**:319-324. DOI: 10.1016/j. bbrc.2013.05.101

[32] Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, et al. Clinical significance of the expression of long non-coding RNA *HOTAIR* in primary hepatocellular carcinoma. Oncology Reports. 2013;**29**:946-950. DOI: 10.3892/ or.2012.2219

[33] Sun W, Yang Y, Xu C, Xie Y, Guo J. Roles of long noncoding RNAs in gastric cancer and their clinical applications. Journal of Cancer Research and Clinical Oncology. 2016;**142**:2231-2237. DOI: 10.1007/s00432-016-2183-7

[34] Svoboda M, Slyskova J, Schneiderova M, Makovicky P, Bielik L, Levy M, et al. *HOTAIR* long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis. 2014;**35**:1510-1515. DOI: 10.1093/carcin/bgu055

[35] Jing L, Yuan W, Ruofan D, Jinjin Y, Haifeng Q. *HOTAIR* enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer. Tumor Biology.

2015;**36**:3611-3619. DOI: 10.1007/ s13277-014-2998-2

[36] Lv X, Lian G, Wang H, Song E, Yao H, Wang M. Long noncoding RNA *HOTAIR* is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;**8**:1-6. DOI: 10.1371/journal. pone.0063516

[37] Teschendorff AE, Lee S, Jones A, Fiegl H, Kalwa M, Wagner W, et al. *HOTAIR* and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Medicine. 2015;**7**:108. DOI: 10.1186/s13073-015-0233-4

[38] Yan Z, He L, Qiu J, Deng W, Lu J, Yuan Z, et al. LncRNA *HOTAIR* participates in the development and progression of adrenocortical carcinoma via regulating cell cycle. European Review for Medical and Pharmacological Sciences. 2018;**22**:6640-6649. DOI: 10.26355/ eurrev\_201810\_16139

[39] Wang B, Qu X-L, Liu J, Lu J, Zhou Z-Y. *HOTAIR* promotes osteosarcoma development by sponging miR-217 and targeting ZEB1. Journal of Cellular Physiology. 2019;**234**: 6173-6181. DOI: 10.1002/jcp.27394

[40] Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F, et al. Long noncoding RNA *HOTAIR* involvement in cancer. Tumor Biology. 2014;**35**:9531-9538. DOI: 10.1007/s13277-014-2523-7

[41] Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-Lail R, Hochberg A, et al. The *H19* non-coding RNA is essential for human tumor growth. PLoS One. 2007;**2**:e845. DOI: 10.1371/ journal.pone.0000845

[42] Dey BK, Pfeifer K, Dutta A. The *H19* long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle

differentiation and regeneration. Genes & Development. 2014;**28**:491-501. DOI: 10.1101/gad.234419.113

[43] Somasundaram S, Forrest ME, Moinova H, Cohen A, Varadan V, LaFramboise T, et al. The *DNMT1* associated lincRNA *DACOR1* reprograms genome-wide DNA methylation in colon cancer. Clinical Epigenetics. 2018;**10**:127. DOI: 10.1186/s13148-018-0555-3

[44] Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, et al. Codingindependent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011;**147**:344- 357. DOI: 10.1016/j.cell.2011.09.029

[45] Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, et al. Pseudogene *PTENP1* functions as a competing endogenous RNA to suppress clearcell renal cell carcinoma progression. Molecular Cancer Therapeutics. 2014;**13**:3086-3097. DOI: 10.1158/1535- 7163.MCT-14-0245

[46] Liu J, Xing Y, Xu L, Chen W, Cao W, Zhang C. Decreased expression of pseudogene *PTENP1* promotes malignant behaviours and is associated with the poor survival of patients with HNSCC. Scientific Reports. 2017;**7**:41179. DOI: 10.1038/srep41179

[47] Poliseno L, Haimovic A, Christos PJ, Vega y Saenz de Miera EC, Shapiro R, Pavlick A, et al. Deletion of *PTENP1* pseudogene in human melanoma. The Journal of Investigative Dermatology. 2011;**131**:2497-2500. DOI: 10.1038/ jid.2011.232

[48] Ioffe YJ, Chiappinelli KB, Mutch DG, Zighelboim I, Goodfellow PJ. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: A conserved regulatory mechanism important in tumorigenesis? Gynecologic Oncology. 2012;**124**:340-346. DOI: 10.1016/j. ygyno.2011.10.011

[49] Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F, et al. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer. Oncotarget. 2017;**8**:26079-26089. DOI: 10.18632/oncotarget.15317

[50] Chen C-L, Tseng Y, Wu J, Chen G, Lin K, Hwang S, et al. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA *PTENP1* and MicroRNA regulation. Biomaterials. 2015;**44**:71-81. DOI: 10.1016/j. biomaterials.2014.12.023

[51] Chen D, Ju H, Lu Y, Chen L, Zeng Z, Zhang D, et al. Long non-coding RNA *XIST* regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. Journal of Experimental & Clinical Cancer Research. 2016;**35**:142. DOI: 10.1186/s13046-016-0420-1

[52] Wu X, Dinglin X, Wang X, Luo W, Shen Q, Li Y. Long noncoding RNA *XIST* promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2. Oncotarget. 2017;**8**:76015-76028

[53] Brown JA, Bulkley D, Wang J, Valenstein ML, Yario TA, Steitz TA, et al. Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nature Structural & Molecular Biology. 2014;**21**:633-640. DOI: 10.1038/ nsmb.2844

[54] Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nature Reviews. Genetics. 2016;**17**:47-62. DOI: 10.1038/nrg.2015.10

[55] Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell

**135**

*The Function of lncRNAs as Epigenetic Regulators DOI: http://dx.doi.org/10.5772/intechopen.88071*

> on *UCA1* in colorectal Cancer. Cancers. 2018;**10**:440. DOI: 10.3390/

[63] Wang X, Gong Y, Jin B, Wu C, Yang J, Wang L, et al. Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells. Oncology Reports. 2014;**32**:1281-1290. DOI: 10.3892/

[64] Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, et al. The long

10.1016/j.stem.2015.03.003

10.1073/pnas.1608585113

10.1038/onc.2010.568

[65] Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, et al. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer. Proceedings of the National Academy of Sciences. 2016;**113**:E7535-E7544. DOI:

[66] Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding RNA *ANRIL* is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene. Oncogene. 2011;**30**:1956-1962. DOI:

[67] Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Research. 2010;**70**:2350-2358. DOI: 10.1158/0008-5472.CAN-09-3885

[68] Wu Y, Lyu H, Liu H, Shi X, Song Y, Liu B. Downregulation of the long noncoding RNA *GAS5*-AS1 contributes to tumor metastasis in non-small cell lung cancer. Scientific Reports. 2016;**6**:31093. DOI: 10.1038/

srep31093

noncoding RNA lncTCF7 promotes selfrenewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;**16**:413-425. DOI:

cancers10110440

or.2014.3309

8031-8041. DOI: 10.1038/sj.onc.1206928

[56] Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer, RNA Biology. 2019;**16**:860-863. DOI: 10.1080/15476286.2019.1592072

[57] Ge Y, He Y, Jiang M, Luo D, Huan X, Wang W, et al. Polymorphisms in lncRNA PTENP1 and the risk of gastric cancer in a Chinese population. Disease Markers. 2017;**2017**:1-8. DOI:

[58] Panzitt K, Tschernatsch MMO, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007;**132**:330-342. DOI: 10.1053/j.gastro.2006.08.026

[59] Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. European Journal of Gastroenterology & Hepatology. 2009;**21**:688-692. DOI: 10.1097/ MEG.0b013e328306a3a2

[60] Sun T-T, He J, Liang Q, Ren L-L, Yan T-T, Yu T-C, et al. LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discovery. 2016;**6**:784-801. DOI: 10.1158/2159-8290.CD-15-0921

[61] Wang C, Wang L, Ding Y, Lu X, Zhang G, Yang J, et al. lncRNA

10.3390/ijms18122659

structural characteristics in epigenetic regulation. International Journal of Molecular Sciences. 2017;**18**:e2659. DOI:

[62] Neve B, Jonckheere N, Vincent A, Van Seuningen I. Epigenetic regulation by lncRNAs: An overview focused

10.1155/2017/6807452

lung cancer. Oncogene. 2003;**22**:

*The Function of lncRNAs as Epigenetic Regulators DOI: http://dx.doi.org/10.5772/intechopen.88071*

*Non-Coding RNAs*

10.1101/gad.234419.113

differentiation and regeneration. Genes & Development. 2014;**28**:491-501. DOI: [49] Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F, et al. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer. Oncotarget. 2017;**8**:26079-26089. DOI:

[50] Chen C-L, Tseng Y, Wu J, Chen G, Lin K, Hwang S, et al. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA *PTENP1* and MicroRNA regulation. Biomaterials. 2015;**44**:71-81. DOI: 10.1016/j. biomaterials.2014.12.023

[51] Chen D, Ju H, Lu Y, Chen L, Zeng Z, Zhang D, et al. Long non-coding RNA *XIST* regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. Journal of Experimental & Clinical Cancer Research. 2016;**35**:142. DOI: 10.1186/s13046-016-0420-1

[52] Wu X, Dinglin X, Wang X, Luo W, Shen Q, Li Y. Long noncoding RNA *XIST* promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2. Oncotarget. 2017;**8**:76015-76028

[53] Brown JA, Bulkley D, Wang J, Valenstein ML, Yario TA, Steitz TA, et al. Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nature Structural & Molecular Biology. 2014;**21**:633-640. DOI: 10.1038/

[54] Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nature Reviews. Genetics. 2016;**17**:47-62. DOI:

Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell

[55] Ji P, Diederichs S, Wang W, Böing S,

nsmb.2844

10.1038/nrg.2015.10

10.18632/oncotarget.15317

[43] Somasundaram S, Forrest ME, Moinova H, Cohen A, Varadan V, LaFramboise T, et al. The *DNMT1* associated lincRNA *DACOR1* reprograms genome-wide DNA methylation in colon cancer. Clinical Epigenetics. 2018;**10**:127.

DOI: 10.1186/s13148-018-0555-3

Tan SM, Ala U, et al. Coding-

7163.MCT-14-0245

[44] Tay Y, Kats L, Salmena L, Weiss D,

independent regulation of the tumor suppressor PTEN by competing

endogenous mRNAs. Cell. 2011;**147**:344- 357. DOI: 10.1016/j.cell.2011.09.029

[45] Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, et al. Pseudogene *PTENP1* functions as a competing endogenous RNA to suppress clearcell renal cell carcinoma progression. Molecular Cancer Therapeutics. 2014;**13**:3086-3097. DOI: 10.1158/1535-

[46] Liu J, Xing Y, Xu L, Chen W, Cao W,

[47] Poliseno L, Haimovic A, Christos PJ, Vega y Saenz de Miera EC, Shapiro R, Pavlick A, et al. Deletion of *PTENP1* pseudogene in human melanoma. The Journal of Investigative Dermatology. 2011;**131**:2497-2500. DOI: 10.1038/

[48] Ioffe YJ, Chiappinelli KB, Mutch DG,

Zighelboim I, Goodfellow PJ. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: A conserved regulatory mechanism important in tumorigenesis? Gynecologic Oncology. 2012;**124**:340-346. DOI: 10.1016/j.

Zhang C. Decreased expression of pseudogene *PTENP1* promotes malignant behaviours and is associated with the poor survival of patients with HNSCC. Scientific Reports. 2017;**7**:41179. DOI: 10.1038/srep41179

**134**

jid.2011.232

ygyno.2011.10.011

lung cancer. Oncogene. 2003;**22**: 8031-8041. DOI: 10.1038/sj.onc.1206928

[56] Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer, RNA Biology. 2019;**16**:860-863. DOI: 10.1080/15476286.2019.1592072

[57] Ge Y, He Y, Jiang M, Luo D, Huan X, Wang W, et al. Polymorphisms in lncRNA PTENP1 and the risk of gastric cancer in a Chinese population. Disease Markers. 2017;**2017**:1-8. DOI: 10.1155/2017/6807452

[58] Panzitt K, Tschernatsch MMO, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007;**132**:330-342. DOI: 10.1053/j.gastro.2006.08.026

[59] Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. European Journal of Gastroenterology & Hepatology. 2009;**21**:688-692. DOI: 10.1097/ MEG.0b013e328306a3a2

[60] Sun T-T, He J, Liang Q, Ren L-L, Yan T-T, Yu T-C, et al. LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discovery. 2016;**6**:784-801. DOI: 10.1158/2159-8290.CD-15-0921

[61] Wang C, Wang L, Ding Y, Lu X, Zhang G, Yang J, et al. lncRNA structural characteristics in epigenetic regulation. International Journal of Molecular Sciences. 2017;**18**:e2659. DOI: 10.3390/ijms18122659

[62] Neve B, Jonckheere N, Vincent A, Van Seuningen I. Epigenetic regulation by lncRNAs: An overview focused

on *UCA1* in colorectal Cancer. Cancers. 2018;**10**:440. DOI: 10.3390/ cancers10110440

[63] Wang X, Gong Y, Jin B, Wu C, Yang J, Wang L, et al. Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells. Oncology Reports. 2014;**32**:1281-1290. DOI: 10.3892/ or.2014.3309

[64] Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, et al. The long noncoding RNA lncTCF7 promotes selfrenewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;**16**:413-425. DOI: 10.1016/j.stem.2015.03.003

[65] Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, et al. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer. Proceedings of the National Academy of Sciences. 2016;**113**:E7535-E7544. DOI: 10.1073/pnas.1608585113

[66] Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding RNA *ANRIL* is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene. Oncogene. 2011;**30**:1956-1962. DOI: 10.1038/onc.2010.568

[67] Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Research. 2010;**70**:2350-2358. DOI: 10.1158/0008-5472.CAN-09-3885

[68] Wu Y, Lyu H, Liu H, Shi X, Song Y, Liu B. Downregulation of the long noncoding RNA *GAS5*-AS1 contributes to tumor metastasis in non-small cell lung cancer. Scientific Reports. 2016;**6**:31093. DOI: 10.1038/ srep31093

[69] Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;**29**:452-463. DOI: 10.1097/ACI.0000000000000108. Anti-Interleukin

[70] Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6Aseq. Nature. 2012;**485**:201-206. DOI: 10.1038/nature11112

[71] Xie Q, Lin S, Zheng M, Cai Q, Tu Y. Long noncoding RNA *NEAT1* promotes the growth of cervical cancer cells via sponging miR-9-5p. Biochemistry and Cell Biology. 2019;**97**:100-108. DOI: 10.1139/bcb-2018-0111

[72] Qi L, Liu F, Zhang F, Zhang S, Lv L, Bi Y, et al. lncRNA *NEAT1* competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis. Biomedicine & Pharmacotherapy. 2018;**103**:1507-1515. DOI: 10.1016/j.biopha.2018.04.053

[73] Ning L, Li Z, Wei D, Chen H, Yang C. LncRNA, *NEAT1* is a prognosis biomarker and regulates cancer progression via epithelialmesenchymal transition in clear cell renal cell carcinoma. Cancer Biomarkers. 2017;**19**:75-83. DOI: 10.3233/CBM-160376

[74] Kong R, Zhang E, Yin D, You L, Xu T, Chen W, et al. Long noncoding RNA *PVT1* indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Molecular Cancer. 2015;**14**:82. DOI: 10.1186/ s12943-015-0355-8

[75] Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell. 2012;**149**:1635-1646. DOI: 10.1016/j. cell.2012.05.003

*Non-Coding RNAs*

Anti-Interleukin

10.1038/nature11112

10.1139/bcb-2018-0111

[69] Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;**29**:452-463. DOI: 10.1097/ACI.0000000000000108.

[70] Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6Aseq. Nature. 2012;**485**:201-206. DOI:

[71] Xie Q, Lin S, Zheng M, Cai Q, Tu Y. Long noncoding RNA *NEAT1* promotes the growth of cervical cancer cells via sponging miR-9-5p. Biochemistry and Cell Biology. 2019;**97**:100-108. DOI:

[72] Qi L, Liu F, Zhang F, Zhang S, Lv L, Bi Y, et al. lncRNA *NEAT1*

and metastasis. Biomedicine &

[73] Ning L, Li Z, Wei D, Chen H, Yang C. LncRNA, *NEAT1* is a prognosis biomarker and regulates cancer progression via epithelialmesenchymal transition in clear cell renal cell carcinoma. Cancer Biomarkers. 2017;**19**:75-83. DOI: 10.3233/CBM-160376

[74] Kong R, Zhang E, Yin D, You L, Xu T, Chen W, et al. Long noncoding RNA *PVT1* indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Molecular Cancer. 2015;**14**:82. DOI: 10.1186/

[75] Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell. 2012;**149**:1635-1646. DOI: 10.1016/j.

s12943-015-0355-8

cell.2012.05.003

competes against let-7a to contribute to non-small cell lung cancer proliferation

Pharmacotherapy. 2018;**103**:1507-1515. DOI: 10.1016/j.biopha.2018.04.053

**136**
